CPIX (STOCKS)
Cumberland Pharmaceuticals Inc
$7.900000
-0.010000 (-0.13%)
Prev close: $7.910000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- A. J. Kazimi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $130.57M
- Employees
- 91
- P/E (TTM)
- -10.84
- P/B (TTM)
- 6.80
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.20 | $0.00 | +0.0000 | +0.00% |
|
Mar 2026 (Q1)
|
$-0.13 | $0.00 | +0.0000 | +0.00% |
|
Dec 2025 (Q4)
|
$-0.01 | $0.00 | +0.0000 | +0.00% |
|
Sep 2025 (Q3)
|
$-0.06 | $0.00 | +0.0000 | +0.00% |
Financial Statements
| Revenues | $22.30M |
| Benefits Costs and Expenses | $31.63M |
| Costs And Expenses | $31.79M |
| Operating Expenses | $31.73M |
| Research and Development | $5.03M |
| Other Operating Expenses | $30.70M |
| Operating Income/Loss | -$9.43M |
| Income/Loss From Continuing Operations After Tax | -$9.34M |
| Income/Loss From Continuing Operations Before Tax | -$9.33M |
| Income Tax Expense/Benefit | $36.66K |
| Interest Expense, Operating | $309.20K |
| Net Income/Loss | -$10.94M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$20.70K |
| Net Income/Loss Attributable To Parent | -$10.92M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.92M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.73 |
| Diluted Earnings Per Share | -$0.73 |
| Basic Average Shares | 44,801,026 |
| Diluted Average Shares | 44,801,026 |
| Assets | $62.88M |
| Current Assets | $33.64M |
| Inventory | $29.94K |
| Other Current Assets | $33.61M |
| Noncurrent Assets | $29.24M |
| Fixed Assets | $248.81K |
| Other Non-current Assets | $28.99M |
| Liabilities | $45.77M |
| Current Liabilities | $35.19M |
| Accounts Payable | $19.55M |
| Other Current Liabilities | $15.64M |
| Noncurrent Liabilities | $10.58M |
| Equity | $17.11M |
| Equity Attributable To Noncontrolling Interest | -$331.57K |
| Equity Attributable To Parent | $17.44M |
| Liabilities And Equity | $62.88M |
| Net Cash Flow From Operating Activities | $745.97K |
| Net Cash Flow From Operating Activities, Continuing | $2.14M |
| Net Cash Flow From Investing Activities | -$5.75M |
| Net Cash Flow From Investing Activities, Continuing | -$6.46M |
| Net Cash Flow From Financing Activities | -$7.22M |
| Net Cash Flow From Financing Activities, Continuing | -$7.03M |
| Net Cash Flow | -$12.22M |
| Net Cash Flow, Continuing | -$11.35M |
| Comprehensive Income/Loss | -$10.94M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.94M |
| Other Comprehensive Income/Loss | $0.00 |